Delivery Order SPE2DB20D1100-SPE2DB25FD1D3
Award Date
6/26/25
Potential Completion Date
6/27/25
Potential Value
$8.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HEMABATE 250 MCG/ML AMPULML, a medical product, with a ceiling value of $1,271.85 and a performance period ending on June 27, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This is a federal contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a ceiling value of $2,543.70 and a firm fixed price pricing type. The contract is for HEMABATE 250 MCG/ML AMPUL/ML, a pharmaceutical product, with a period of performance through June 6, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HEMABATE 250 MCG/ML AMPULML, a pharmaceutical product, with a ceiling value of $1,656.93 and a performance period through May 28, 2025. The contract is not set-aside and was awarded on May 27, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,368.33, is for the delivery of HEMABATE 250 MCG/ML AMPUL/ML medical supplies. The contract is a firm fixed-price delivery order that does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of HEMABATE 250 MCG/ML AMPULML medical products. The contract has a ceiling value of $3,567.20 and an ultimate completion date of June 11, 2025. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the procurement of HEMABATE 250 MCG/ML AMPULML, a specialty pharmaceutical product, with a potential value of $1,097.24 and a completion date of February 1, 2024. This award is not associated with any set-aside designation....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of HEMABATE 250 MCG/ML AMPULML, a prescription medication. The firm-fixed-price contract has a ceiling value of $7,484.47 and a period of performance through August 29, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,180.16, is for the supply of HEMABATE 250 MCG/ML AMPULML, a specialty medication. The delivery order has a firm fixed-price pricing type and an ultimate completion date of December 2, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HEMABATE 250 MCG/ML AMPULML. The contract has a ceiling value of $1,813.85 and runs through September 27, 2024. It is a firm fixed-price contract, with no set-aside designation. As a key supplier of pharmaceuticals and medical supplies to the U.S. government, AmerisourceBergen has been awarded numerous Indefinite Delivery...
This federal contract award is for the delivery of HEMABATE 250 MCG/ML AMPULML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,097.24 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract has an ultimate completion date of May 24, 2024 and was awarded on May 23, 2024. It is not set aside for any special designation. Amerisourcebergen, a subsidiary...